Get reviewed by the people
who decide what gets published.

I'd had a desk rejection from Nature two months earlier and didn't fully understand why. The reviewer Manusights matched me with had reviewed for Nature Immunology for seven years. He spent twenty minutes explaining that my mechanistic claim in the abstract was three experiments short of being defensible at that tier, and that the work I'd already done was actually stronger than I was presenting it. I restructured the introduction, added two validation experiments he outlined specifically, and resubmitted to Nature Immunology. Revise and resubmit after the first round. Accepted three months later.

My study crossed three disciplines and I wasn't sure whether JCI's editors would see it as translational enough or too basic. The reviewer had published in JCI four times and reviewed for them regularly. She told me specifically that JCI's editorial team had shifted toward wanting patient-derived validation before they'd treat mechanism-only data as compelling. I had the patient cohort data buried in supplementary. We moved it up front, rewrote the abstract around it, and the paper got sent for peer review. Minor revision, accepted.

I showed the manuscript to four people in my lab and two collaborators before using Manusights. None of them caught what the reviewer found: two of my main conclusions were supported by correlation data, not causation, and Cancer Cell's reviewers would almost certainly request functional experiments to close that gap. He ranked which experiments were essential versus optional. I ran three of them over the next few months, resubmitted, and got a minor revision. I spent roughly $1,400 on the review and probably saved six months of post-rejection revision time.

English isn't my first language, and I was worried about framing my findings the way Western journals expect translational work to be presented. The reviewer had published six papers in the Cell family and knew exactly how Cell Reports Medicine positions itself relative to Cell and Nature Medicine. He pointed out that I was describing my clinical findings in a way that undersold the novelty, and helped me reframe three key paragraphs. Accepted after one round of minor revisions. I've recommended this to every postdoc in my department since.